EMAIL DETAILS

Great seeing everyone and spending the time in make up!

Fantastic update on Counsyl!

Devon Archer
646 436 3745

> On Feb 7, 2014, at 5:50 PM, John DeLoche <john@rstp.com> wrote:
>
> Gents,
>
> Great seeing you all in NY and DC this week. We are on our way to building the world's best growth equity firm.
>
> I just got off the Counsyl Q4 update call and they continue to crush it. Update is below:
>
> $48.3mm revenues in 2013
>
> Forecasting $88mm to $100mm for 2014
>
> Grew salesforce from 30 to 60 people last year. Growing salesforce to 100 people in 2014
>
> International expansion. hiring someone this month. Will determine what markets to enter in Q1/Q2.
>
> Plan to complete CFO hire by end of Q1.
>
> Spring marketing relaunch and new website in May. Likely large growth equity round in 2h 2014, IPO in 2015
>
> 33k requisitions in Q4 which was 7% QoQ growth
>
> Introduced breast cancer (BRCA) test last year. 5k BRCA tests by Q4 2014
>
> Expanding into hereditary cancer testing as well as newborn screening. Timing of hereditary cancer test introduction is Q1 2015.
>
> There is an in person board meeting next week and I will send a further update then.
>
> Best,
>
> John
>
> John DeLoche
> Managing Director
> Rosemont Seneca Technology Partners
> 333 Bush Street, 21st Floor
> San Francisco, CA 94104
> office: 415 767 1288
> mobile: 415 793 7070
>
> This email communication is privileged and confidential and is intended only for the individuals or entities named above. Any unauthorized dissemination of any of the contents of this email is strictly prohibited. If you are not the intended recipient, please do not read, copy, use or disclose to others the contents of this communication. Please notify the sender that you have received this e-mail in error and then delete the e-mail